Stockreport

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. [Yahoo! Finance]

ImmunoPrecise Antibodies Ltd.  (IPA) 
PDF Partnership advances next-generation ADCs and bispecific antibodies to address unmet medical needs AUSTIN, Texas, March 13, 2025 BUSINESS WIRE )--ImmunoPrecise Antibo [Read more]